Published in Jama Network Open, researchers have correlated higher opioid use in parts of the country where biopharma spend more money on marketing. This shouldn’t be a surprise. The Boston and New York-based researchers found that between August 2013 and December 2015, biopharma spent roughly $40 million on opioid marketing to more than 67,000 physicians. The highest concentration of marketing occurred in the Northeast while the lowest included the Midwest. Interestingly, for each three additional payments transferred to physicians per 100,000 people in a county, opioid deaths increased 18%.
The following research centers were involved with this effort:
- Boston University School of Medicine, Division of General Pediatrics
- Boston Medical Center, Department of Pediatrics, Grayken Center for Addiction
- University of California, Davis, Department of Emergency Medicine
- New York University School of Medicine, Department of Population Health
- Brown University School of Public Health, Department of Epidemiology
- Category: Opioids, Adverse Events, Deaths, Marketing